Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems

Ozlem Gun Eryilmaz, Aysun Devran, Esma Sarikaya, Fatma Nur Aksakal, Leyla Mollamahmutoğlu, Nedim Cicek, Ozlem Gun Eryilmaz, Aysun Devran, Esma Sarikaya, Fatma Nur Aksakal, Leyla Mollamahmutoğlu, Nedim Cicek

Abstract

Purpose: We aimed to analyse the in vitro fertilization-embryo transfer (IVF-ET) outcomes of the patients with sleep disturbances who were administered melatonin.

Methods: A total of 60 patients with sleep disturbances were divided into two groups. The study group (group A, n=30) had underwent the IVF-ET with melatonin administration and the control group (group B, n=30) without melatonin. Sleeping status after melatonin administration and the IVF outcomes were compared between the two groups.

Results: Sleeping status change was not significant (p>0.05). The mean number of the retrieved oocytes, the mean MII oocyte counts, the G1 embryo ratio were significantly higher in the melatonin administered group (group A) than that the non-administered group (group B); p=0.0001; p=0.0001; p<0.05 respectively.

Conclusion: IVF patients with sleep disorders may benefit from melatonin administration in improving the oocyte and the embryo quality, but the sleeping problem itself may not be fixed.

Figures

Fig. 1
Fig. 1
Flow diagram of the patients who received melatonin and not received melatonin

References

    1. Pal L, Bevilacqua K, Zeitlian G, Shu J, Santoro N. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause. 2008;15(6):1086–1094. doi: 10.1097/gme.0b013e3181728467.
    1. Thierring P, Beaurepaire J, Jones M, Sounders D, Tennant C. Mood state as a predictor of treatment outcome after in vitro fertilization/embryo transfer technology (IVF/ET) J Psychosom Res. 1993;37:481–491. doi: 10.1016/0022-3999(93)90004-Y.
    1. Cousineu TM, Domar A. Psychological impact of infertility. Best Pract Res Clin Obstet Gynecol. 2007;21:293–308. doi: 10.1016/j.bpobgyn.2006.12.003.
    1. Demyttenaere K, Bonte L, Gheldof M, Vervaeke M, Meuleman C, Vanderschuerem D, et al. Coping style and depression level influence outcome in in vitro fertilization. Fertil Steril. 1998;69:1026–1033. doi: 10.1016/S0015-0282(98)00089-2.
    1. Kee BS, Jung BJ, Lee SH. A study on psychological strain in IVF patients. J Assist Reprod Genet. 2000;17:445–448. doi: 10.1023/A:1009417302758.
    1. Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF treatment: psychological and endocrinological assessment of Swedish women entering IVF treatment. Acta Obstet Gynecol Scand. 2000;79:113–118. doi: 10.1034/j.1600-0412.2000.079002113.x.
    1. Klonoff-Cohen H, Chu E, Natarajan L, Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamate intrafallopian transfer. Fertil Steril. 2001;76:675–687. doi: 10.1016/S0015-0282(01)02008-8.
    1. Ohayon MM. Insomnia: a ticking clock for depression? J Psychiatr Res. 2007;41(11):893. doi: 10.1016/j.jpsychires.2007.07.008.
    1. Isaac F, Greenwood KM. The relationship between insomnia and depressive symptoms: genuine or artifact? Neuropsychiatr Dis Treat. 2011;7:57. doi: 10.2147/NDT.S16267.
    1. Dodson ER, Zee PC. Therapeutics for circadian rhythm sleep disorders. Sleep Med Clin. 2010;5:701–715. doi: 10.1016/j.jsmc.2010.08.001.
    1. Tan DX, Manchester LC, Sainz RM, Mayo JC, Leon J, Hardeland R, et al. Interaction between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res. 2005;39:185–194. doi: 10.1111/j.1600-079X.2005.00234.x.
    1. Reiter RJ, Tan DX, Maldenado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res. 2005;39:215–216. doi: 10.1111/j.1600-079X.2005.00261.x.
    1. Ferreira ZS, Markus RP. Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol. 2007;151(2):195–205. doi: 10.1038/sj.bjp.0707225.
    1. Pappolla MA, Chyan YJ, Poeggeler B, Frangione B, Wilson G, Ghiso J, et al. An assessment of the antioxidant and the antimyloidogenic properties of melatonin: implications for Alzheimer’s disease. J Neural Transm. 2000;107:203–231. doi: 10.1007/s007020050018.
    1. Bonilla E, Valero N, Chacin-Bonilla L, Medina-Leendertz S. Melatonin and viral infections. J Pineal Res. 2004;36:73–79. doi: 10.1046/j.1600-079X.2003.00105.x.
    1. Hussain SA, Khadim HM, Khalaf BH, Ismail SH, Hussein KI, Sahib AS. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J. 2006;27:1483–1488.
    1. Ishizuka B, Kuribayashi Y, Murai K, Amemiya A, Itoh MT. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res. 2000;28:48–51. doi: 10.1034/j.1600-079x.2000.280107.x.
    1. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011 Apr 5. [Epub ahead of print].
    1. Berlinguer F, Leoni GG, Succu S, Spezzigu A, Madeddu M, Satta V, et al. Exogenous melatonin positively influences follicular dynamics, oocyte developmental competence and blastocyst output in a goat model. J Pineal Res. 2009;46:383–391. doi: 10.1111/j.1600-079X.2009.00674.x.
    1. Vázquez MI, Forcada F, Casao A, Abecia JA, Sosa C, Palacín I. Undernutrition and exogenous melatonin can affect the in vitro developmental competence of ovine oocytes on a seasonal basis. Reprod Domest Anim. 2010;45:677–684.
    1. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, et al. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 2009;92(1):328–343. doi: 10.1016/j.fertnstert.2008.05.016.
    1. Woo MMM, Tai CJ, Kang SK, Nathwani PM, Pang SF, Leung PCK. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab. 2001;86:4789–4797. doi: 10.1210/jc.86.10.4789.
    1. Hemadi M, Abolhassani F, Akbari M, Sobhani A, Pasbakhsh P, Ährlund-Richter L, et al. Melatonin promotes the annulus-oocyte complexes quality of vitrified-thawed murine ovaries; with increased mean number of follicles survival and ovary size following heterotropic transplantation. Eur J Pharm. 2009;618:84–90. doi: 10.1016/j.ejphar.2009.07.018.
    1. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2007;44:280–287. doi: 10.1111/j.1600-079X.2007.00524.x.
    1. Forcada F, Abecia JA, Casao A, Cebrián-Pérez JA, Muiño-Blanco T, Palacín I. Effects of ageing and exogenous melatonin on pituitary responsiveness to GnRH in ewes during anestrus and the reproductive season. Theriogenology. 2007;67(4):855–862. doi: 10.1016/j.theriogenology.2006.11.002.
    1. WHO Laboratory Manual for the examination and processing of human semen. 5. Geneva: World Health Organization; 2010.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburg Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Agargün MY, Kara H, Anlar O. Pittsburg uyku kalitesi indeksinin geçerliliği ve güvenilirliği. Turk Psikiatri Dergisi. 1996;7:107–115.
    1. Simpson D, Curran MP. Ramelteon: a review of its use in insomnia. Drugs. 2008;68(13):1901–1919. doi: 10.2165/00003495-200868130-00011.
    1. Farhi J, Ben-Haroush A. Distribution of causes of infertility in patients attending primary fertility clinics in Israel. Isr Med Assoc J. 2011;13(1):51–54.
    1. Gurgan T, Urman B, Yaralı H, Kisnisci H. The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination. Fertil Steril. 1995;64(1):93–97.
    1. Abecia JA, Forcada F, Zuniga O. The effect of melatonin on the secretion of progesterone in sheep and on the development of ovine embryos in vitro. Vet Res Commun. 2002;26:151–158. doi: 10.1023/A:1014099719034.
    1. Karakaş A, Kaya A, Gündüz B. The effect of pinealectomy, melatonin and leptin hormones on ovarian follicular development in female Syrian hamsters (Mesocricetus auratus) Acta Biol Hung. 2010;61(4):380–390. doi: 10.1556/ABiol.61.2010.4.2.
    1. Reiter RJ, Rollag MD, Panke ES, Banks AF. Melatonin: reproductive effects. J Neural Transm Suppl. 1978;13:209–223.
    1. Zuelka KA, Jones DP, Perreault SD. Glutathione oxidation is associated with altered microtubule function and disrupted fertilization in mature hamster oocytes. Biol Reprod. 1997;57:1413–1419. doi: 10.1095/biolreprod57.6.1413.
    1. Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective clinical trial. Eur Rev Med Pharmacol Sci. 2010;14:555–561.
    1. Adriaens I, Jacquet P, Cortvrindt R, Janssen K, Smitz J. Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology. 2006;228:333–343. doi: 10.1016/j.tox.2006.09.018.
    1. Paszkowski T, Clarke RN. Antioxidant capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod. 1996;11:2493–2495.
    1. Harvey AJ, Kind KL, Thompson JG. REDOX regulation of early embryo development. Reproduction. 2002;123:479–486. doi: 10.1530/rep.0.1230479.
    1. Veeck LL. Oocyte assessment and biological performance. Ann NY Acad Sci. 1988;541:259–274. doi: 10.1111/j.1749-6632.1988.tb22263.x.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe